We help investors find and evaluate biotech investments
We help biotech startups with financial and product strategy so you can raise money and grow your business
Technical and business diligence
Screen deal flow
Research a new area and find interesting companies (or start one in house)
Find and vet candidates for associate / analyst hires
Evaluate which products or indications to pursue
Fundraising and financial strategy
Competitive analysis and landscape mapping
Fundraising presentations and financial models
Cost-effectiveness analysis
References available upon request
Sign up for our newsletter and we'll email you a case study
The right expertise for your project
We assemble project teams with the expertise you need: academic scientists, experienced industry scientists, attorneys, clinicians and investors.
Data-driven insights
Rigorous analysis and evidence-based recommendations. Our executive summaries save you time, and we present the full chain of evidence so you can dive as deeper where necessary.
Respect for your time
We have years of experience delivering results for Fortune 10 executives, venture and angel investors, and startup CEOs. We understand the value of your time and adapt to your style of working.
Fast and flexible
We combine the pace of startups with the quality of big companies. Whether it is a simple analysis or mission-critical project, we communicate clearly, execute quickly, and deliver quality results.
We assemble project teams tailored for each project. Our teams are composed of scientists from academia and industry, lawyers, analysts, clinicians and professionals. Our core team is involved in client relations, project management and team formation in addition to working on projects.
Richard Murphey is a former biotech venture / growth investor, co-founder of a venture-backed biotherapeutics startup, and has supported several biotech startups as an independent consultant. He has been involved with venture investments in Kythera, Aptalis, and Raptor Pharmaceuticals among others.
Vandon Duong is the Managing Partner at Mythos Biotechnology Fund, an investment fund consisting of graduate and medical students and postdocs from Stanford University. Vandon is a Bioengineering PhD student (co-advised in protein and cell engineering labs) and Stanford Graduate Fellow.